Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01921569 · ClinicalTrials.gov registry record · NA
Micronized Dehydrated Human Amniotic Membrane Suspension in the Treatment of Lateral Epicondylitis
A NA study, sponsored by MiMedx Group.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT01921569: Clinical Trial NA study, sponsored by MiMedx Group.
NCT01921569 is a NA study that was terminated before completion, run by MiMedx Group. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01921569, a NA study, was terminated before completion, sponsored by MiMedx Group.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether micronized dehydrated human amniotic membrane (dHACM) suspension is more effective in reducing inflammation than conservative measures alone when used to treat acute/early lateral epicondylitis.
Interventions
- BEHAVIORAL Standard of Care Therapy
- OTHER dHACM Injection
- OTHER Normal Saline Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2013-06 |
| Est. Completion | 2014-03 |
| Phase | NA |
Why NCT01921569 stopped before completion
NCT01921569 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 3 interventions - of which Standard of Care Therapy is the first listed.
NCT01921569 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01921569 about?
NCT01921569 is a clinical study titled "Micronized Dehydrated Human Amniotic Membrane Suspension in the Treatment of Lateral Epicondylitis". The purpose of this study is to determine whether micronized dehydrated human amniotic membrane (dHACM) suspension is more effective in reducing inflammation than conservative measures alone when used to treat acute/early lateral epicondylitis.
What is the current status of trial NCT01921569?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2013-06. Estimated completion is 2014-03.
What interventions are being tested in trial NCT01921569?
The interventions under investigation include: Standard of Care Therapy (BEHAVIORAL), dHACM Injection (OTHER), Normal Saline Injection (OTHER).
Who is sponsoring clinical trial NCT01921569?
This trial is sponsored by MiMedx Group, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01921569's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia